Skip to main content

Dr. Salman Otoukesh

Hematology (Hematology (Internal Medicine) Physician)

1500 E. Duarte Road
Duarte, CA 91010

Who else practices at this address →

Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas

Call (626) 256-4673

  • Medicare participating

At a glance

Years since graduation
20
In the NPI registry since
2013
Medicare patients seen, 2024
169

Licensed in California since 2015, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2013Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology (Internal Medicine) Physician primary
    CA license A139997 (first issued 2015; current)
  • Internal Medicine Physician
    TX license BP10047617

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology per capita by county →

Where they work

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
169
Services billed
1,553
Patients’ average age
72
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes37969
Established patient office or other outpatient visit, 40-54 minutes33064
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes13234
Established patient office or other outpatient visit, 30-39 minutes5031
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes1614
Hospital discharge day management, more than 30 minutes1515
New patient office or other outpatient visit, 60-74 minutes1414

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Jakafi (ruxolitinib phosphate)38
Ondansetron Hcl
Other prescribers in Duarte, CA
18
Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim)
Other prescribers in Duarte, CA
17
Hydroxyurea
Other prescribers in Duarte, CA
17
Pantoprazole Sodium
Other prescribers in Duarte, CA
16
Acyclovir
Other prescribers in Duarte, CA
14
Imatinib Mesylate14
Posaconazole14
Sodium Chloride (0.9 % sodium chloride)
Other prescribers in Duarte, CA
11
Idhifa (enasidenib mesylate)11

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 3 companies reported 3 payments worth $688 in total to this clinician.

By company
Daiichi Sankyo Inc.$650
AbbVie Inc.$21.74
Azurity Pharmaceuticals, Inc.$16.42
By type
Consulting Fee$650
Food and Beverage$38.16

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Sep 22, 2025Daiichi Sankyo Inc.
Sep 22, 2025
Consulting Fee
Vanflyta · ONCOLOGY
$650

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Industry-funded research

Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $671,313 in research payments for these studies, mostly to the institutions running them.

  • A First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-88549968, a T-cell Redirecting Bispecific Antibody for CALR-mutated Myeloproliferative Neoplasms
    Janssen Research & Development, LLC
  • An Open Label, Phase 1/1b Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination with Ruxolitinib in Patients with Myelofibrosis
    Geron Corporation
  • A Phase 1 Study of VAC85135, a Neoantigen Vaccine Regimen, ConcurrentlyAdministered with Ipilimumab for the Treatment of Myeloproliferative Neoplasms
    Janssen Research & Development, LLC
  • Study name not reported
    Pharmaessentia USA Corporation

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology clinicians in Duarte

Sources

NPI registry (CMS NPPES, November 2026; record last updated June 17, 2019), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1225476484. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.